Cite

    Peterson, J. et al. (2019). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Human vaccines & immunotherapeutics. 15 (3), pp. 540-548. [Online].